Document Detail


Acute bacterial endophthalmitis after cataract extraction: results of treatment.
MedLine Citation:
PMID:  11117411     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In order to evaluate the results, we reviewed all 34 patients treated in our hospital for endophthalmitis after cataract surgery between January 1994 and January 1998. After cultures were taken, all patients received intraocular, subconjunctival and topical vancomycin and ceftazidime. Additionally, twelve patients received the same antibiotics systemically. Besides steroids were administered in all patients. In 79% of the patients the bacterial culture was positive. Coagulase negative Staphylococcus was the most frequently isolated microorganism (48%). After treatment a visual acuity of 0.1 or more was achieved in 62% of the patients. The best final results were achieved in the patients with an initial visual acuity of 1/300 or more, and in the patients from whom a coagulase negative Staphylococcus was isolated.
Authors:
M F Versteegh; J M Hooymans; V W De Lavalette; G Van Rij
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article    
Journal Detail:
Title:  Documenta ophthalmologica. Advances in ophthalmology     Volume:  100     ISSN:  0012-4486     ISO Abbreviation:  Doc Ophthalmol     Publication Date:  2000  
Date Detail:
Created Date:  2000-12-14     Completed Date:  2001-02-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370667     Medline TA:  Doc Ophthalmol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  7-15     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Academic Hospital Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Aged
Aged, 80 and over
Cataract Extraction / adverse effects*
Ceftazidime / therapeutic use
Conjunctiva / microbiology
Drug Therapy, Combination / therapeutic use
Endophthalmitis / drug therapy*,  microbiology
Eye Infections, Bacterial / drug therapy*,  microbiology
Humans
Lens Implantation, Intraocular / adverse effects
Middle Aged
Prognosis
Retrospective Studies
Staphylococcal Infections / drug therapy*,  microbiology
Staphylococcus / isolation & purification
Surgical Wound Infection / drug therapy*,  microbiology
Vancomycin / therapeutic use
Visual Acuity
Vitrectomy
Vitreous Body / microbiology
Chemical
Reg. No./Substance:
1404-90-6/Vancomycin; 78439-06-2/Ceftazidime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phacotrabeculectomy.
Next Document:  Retention properties of the fluorinated bonded phase on liquid chromatography of aromatic hydrocarbo...